These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31183974)
1. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients. Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974 [TBL] [Abstract][Full Text] [Related]
2. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression. Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma. Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021 [TBL] [Abstract][Full Text] [Related]
4. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892 [TBL] [Abstract][Full Text] [Related]
5. Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950 [TBL] [Abstract][Full Text] [Related]
7. CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma. Yu YH; Xu JH; Chen H; Lin YX; Ou-Yang J; Zhang ZY Kaohsiung J Med Sci; 2024 Oct; 40(10):926-933. PubMed ID: 39210603 [TBL] [Abstract][Full Text] [Related]
8. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients. Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854 [TBL] [Abstract][Full Text] [Related]
9. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma. Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma. Xie C; Yiu W; Mo Y Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma. Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633 [TBL] [Abstract][Full Text] [Related]
12. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation. Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma. Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618 [TBL] [Abstract][Full Text] [Related]
14. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma. Wei C; Lai YQ; Li XX; Ye JX Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745 [TBL] [Abstract][Full Text] [Related]
15. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma. Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195 [TBL] [Abstract][Full Text] [Related]
16. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma. Pang S; Zhao S; Dongye Y; Fan Y; Liu J Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma. Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418 [TBL] [Abstract][Full Text] [Related]
20. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma. Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]